This can be accomplished by controlling transgene expression using cancer‐induced promoters such as the promoter of the glucose‐regulated protein 78 (GRP78), which is an inducible promoter that is activated by chemotherapy since the GRP78 gene is associated with tumor resistance to treatment.16 This evidence concerns the gene HSPA5 and neoplasm.